News

Pediatric Rheums Advise Assertive JIA Approach


 

Some adult rheumatologists, internists, pediatricians, and even orthopedic surgeons treat JIA with great skill and compassion, all of the experts interviewed for this story agreed. But nonpediatric rheumatologists balk when it comes to prescribing biologic therapies, which require finesse in family communication, administration, and monitoring. As a result, practical access to biologics is spotty and many children still live with preventable pain and progressive disability. As is the case with rheumatoid arthritis in adults, early diagnosis is imperative and disease-modifying drugs must be initiated before irreparable damage occurs, they said.

Pages

Recommended Reading

Biodegradable Valve Ring Favorable in Short Term
MDedge Rheumatology
Methotrexate Improves Quality of Life in JIA
MDedge Rheumatology
In Kids, MRSA Leads to Musculoskeletal Infection
MDedge Rheumatology
Screen Early for TMJ in Juvenile Idiopathic Arthritis
MDedge Rheumatology
Panel Backs Expanding Enbrel to Pediatric Psoriasis
MDedge Rheumatology
Low Vitamin D Seen in Young Musculoskeletal Pain Patients
MDedge Rheumatology
Pediatric SLE: Ethnicity and Age Affect Incidence, Course
MDedge Rheumatology
Lysosomal Storage Disorders: Awareness, Early Action Are Key
MDedge Rheumatology
Blood-Lead Threshold for Kids May Be Too High
MDedge Rheumatology
Follow-Up MRI in Kids With Suspected Osteomyelitis Has Value
MDedge Rheumatology